跳至主要内容
临床试验/NCT06609031
NCT06609031尚未招募不适用

Endoscopic Mucosal Resection Versus Cold Snare Polypectomy in the Treatment of Sessile Serrated Lesions Less Than 10mm in Size: a Single-center, Open-label, Randomized Controlled Trial

Fudan University2 个研究点 分布在 1 个国家目标入组 270 人开始时间: 2024年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
270
试验地点
2
主要终点
R0 resection

研究概览

简要总结

A prospective, single-center, open-label, randomized controlled study to compare the effectiveness and safety of endoscopic mucosal resection (EMR) and cold snare polypectomy (CSP) in treating colorectal sessile serrated lesions (SSLs) less than 10mm in size.

详细描述

  1. Patients are undergone screening, surveillance, or therapeutic colonoscopy at the Endoscopy department of Gastrointestinal endoscopy center of Huadong hospital affiliated to Fudan University.
  2. Randomize patients with suspicious sessile serrated lesions (SSLs) less than 10mm in size into 2 interventional groups based on Random function of Statistical Package for the Social Sciences (SPSS) 20.0, including (1) Group 1: Endoscopic mucosal resection (EMR) and (2) Group 2: Cold snare polypectomy (CSP).
  3. Collecting variables which consist of primary and secodary outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 35 and 75 years
  • Suspected sessile serrated lesions less than 10mm in size in screening, surveillance or therapeutic colonoscopy
  • 0-Is or 0-IIa according to Paris classification
  • Type 1 according to NICE and JNET classification
  • Type II according to pit pattern
  • Patients must sign an informed consent form prior to registration in study

排除标准

  • Unsuitable for removal by EMR or CSP
  • Suspected dysplasia or malignancy
  • Recurrent sessile serrated lesions after endoscopic resection
  • Familial adenomatous polyposis, Lynch syndrome or serrated polyposis syndrome
  • History of inflammatory bowel disease
  • Patients taking anticoagulant and antiplatelet agents before the examination
  • Severe illness or other high-risk conditions that prevent the patient from cooperating with or tolerating endoscopic therapy
  • Refusal to sign the informed consent form or any other factors that are not suitable for enrollment or affect the participant's ability to participate in the study

结局指标

主要结局

R0 resection

时间窗: 2 weeks after the procedure

Rate of R0 resection in treating SSLs less than 10mm in size

次要结局

  • en bloc resection(immediately after the procedure)
  • Vertical margins(2 weeks after the procedure)
  • Lateral margin(2 weeks after the procedure)
  • Presence of muscularis mucosae(2 weeks after the procedure)
  • Presence of submucosa(2 weeks after the procedure)
  • Clinically Significant Immediate Post-polypectomy Bleeding(CSIPB)(immediately after the procedure)
  • Clinically Significant Delayed Post-polypectomy Bleeding(CSDPB)(2 weeks after the procedure)
  • Delayed perforation(2 weeks after the procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhijun Bao

Director

Fudan University

研究点 (2)

Loading locations...

相似试验

EMR Versus CSP in the Treatment of Sessile Serrated... | 临床试验